A Prospective Cohort Study on Serum Glycosylated Fibronectin as a Biomarker for Early Prediction of Preeclampsia
Background: Preeclampsia (PE) is a significant hypertensive disorder of pregnancy contributing to maternal and neonatal morbidity and mortality. Early detection and intervention are crucial to reducing the burden of this disease. Glycosylated fibronectin (GlyFn) has emerged as a potential biomarker...
Saved in:
Main Authors: | Vibhuti Thakur, Kavyashree, Poonam Mathur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-06-01
|
Series: | Journal of Pharmacy and Bioallied Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jpbs.jpbs_277_25 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycosylated fibronectin as a biomarker to predict gestational diabetes mellitus in the first trimester of pregnancy
by: Indu Lata, et al.
Published: (2025-06-01) -
Maternal and Perinatal Outcomes of Early and Late Onset Preeclampsia with Severe Features in Secondary Health Care
by: Aryani Aziz, et al.
Published: (2025-01-01) -
Biomarkers for prediction and diagnostics of preeclampsia
by: O. V. Radkov, et al.
Published: (2018-04-01) -
Iron–Immune Crosstalk at the Maternal–Fetal Interface: Emerging Mechanisms in the Pathogenesis of Preeclampsia
by: Jieyan Zhong, et al.
Published: (2025-07-01) -
Fetal fibronectin and microorganisms in vaginal fluid of women with complicated pregnancies
by: Anette Rossel Goffeng, et al.
Published: (1997-06-01)